Track topics on Twitter Track topics that are important to you
Regeneron reported a GAAP net income of $388 million, or $3.66 per basic share and $3.34 per diluted share, in the second quarter of 2017 compared with a GAAP net income of $196 million, or $1.88 per basic share and $1.69 per diluted share, in 2016’s second quarter.Total revenues increased to $1.470 billion from $1.213 billion in the second quarter of 2016, which includes net product sales of $924 million compared with $834 million in 2016, according to a press release.
Original Article: Regeneron reports $388 million in second-quarter net incomeNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...